Rankings
▼
Calendar
CAMP Q2 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$125M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.80
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$14M
Stock-Based Comp.
$786,000
Balance Sheet
Total Assets
$30M
Total Liabilities
$177M
Stockholders' Equity
-$147M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$71M
-100.0%
Gross Profit
$0
$27M
-100.0%
Operating Income
-$13M
-$3M
-404.7%
Net Income
-$13M
-$4M
-211.9%
← FY 2024
All Quarters
Q3 2024 →